The ESPOIR cohort: A ten-year follow-up of early arthritis in France

The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh et al. · Arthritis & Rheumatism · 2005 · 1.8K citations

Medicine, Pharmacology, Pharmacotherapy +17

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

Lars Klareskog, Désirée van der Heijde, J Jäger et al. · The Lancet · 2004 · 1.8K citations

Medicine, Pharmacology, Pharmacotherapy +10

The mortality of rheumatoid arthritis

Frederick Wolfe, Donald M. Mitchell, John Sibley et al. · Arthritis & Rheumatism · 1994 · 1.3K citations

Medicine, Clinical Sciences, Internal Medicine +16

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

E. William St. Clair, Désirée van der Heijde, Josef S Smolen et al. · Arthritis & Rheumatism · 2004 · 1.2K citations

Medicine, Pharmacology, Pharmacotherapy +12

Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis

Valerie Nell · British journal of rheumatology · 2004 · 816 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16